AI-assisted international press reviewPress review

Johnson & Johnson Acquires Halda Therapeutics to Strengthen Oncology Portfolio

Johnson & Johnson has announced the acquisition of Halda Therapeutics, a clinical-stage biotechnology company, for $3.05 billion. This acquisition aims to integrate innovative targeted therapies for the treatment of prostate cancer and other solid tumors, leveraging Halda's RIPTAC™ technology. The lead candidate, HLD-0915, could transform patient outcomes by targeting cancer cells even in cases of resistance to standard treatments. This move underscores Johnson & Johnson's commitment to innovation in oncology and the expansion of its therapeutic portfolio.

Source: J&j - 17 November 2025

Soils, Inputs & Water

Syngenta's REVERTE® Program Recognized for Agricultural Transformation

Syngenta's REVERTE® program has been awarded Best-in-Class for its innovative approach to transforming agricultural practices. By integrating advanced technologies and sustainable methods, Syngenta demonstrates its commitment to more efficient and environmentally friendly agriculture, while addressing contemporary challenges in food production.

Source: Sygenta Group, published under the title "Syngenta’s REVERTE® program honored as Best-in-Class for tra..." - 17 November 2025

Michelle Davis: 30 Years of Commitment and Expertise at UGL

30 years of loyalty at UGL: Michelle Davis, who started as an accounting clerk in 1995, has climbed the ranks to engineering and SAP expertise, supporting major projects in defense, mining, roads, and telecommunications. "Working on diverse areas with excellent teams has been my highlight," she shares. Today, she boosts the Telco team as a project accountant. A ghost tour enthusiast outside the office!

Source: Cimic - 17 November 2025

West Gate: Major Milestone with the Installation of the Diagrid!

The West Gate Tunnel project reaches a major milestone: the installation of the last diagrid module at the North Portal, completed in August. This complex operation involved 56 crane lifts and the assembly of over 3,000 steel pieces, following six months of intensive work, including 12 weeks of night shifts. Thanks to expert coordination among specialized teams – riggers, crane operators, welders, and scaffolders – this success paves the way for the cladding of the ventilation structure, mirroring the southern section. A feat of collaborative engineering for an ambitious project.

Source: Cimic, published under the title "West Gate reaches major milestone" - 17 November 2025

Mars Unveils Its Festive Treats for the Holidays!

Mars brightens the holidays with its seasonal delights: discover the M&M’S Winter Blend in snowy winter hues, the crunchy TWIX Snowmen shaped like snowmen, and the LIFE SAVERS Gummies in festive patterns like Christmas stockings. Classics return too, with SNICKERS Trees and M&M’S Holiday Blend for cozy moments. Perfect for your movie marathons or family baking, these treats bring joy and flavors to celebrations. Available at retailers! For more ideas, follow on Instagram and TikTok.

Source: Mars Incorporated, published under the title "Mars unwraps holiday cheer with seasonal treats from M&M’S® ..." - 17 November 2025

ACS and GIP Join Forces for a Global Data Center Platform of 1.7 GW

ACS and BlackRock have formed a 50-50 joint venture to revolutionize global data centers. By combining ACS's technological expertise in construction and sustainable energy with GIP's strategic investment, this platform will provide comprehensive solutions: from land acquisition to operation, integrating renewable energy, modular designs, and a significant reduction in environmental impact. Supporting the rise of AI and cloud computing, it starts with a portfolio of 1.7 GW valued at 2 billion euros, positioning the partners as leaders in green digital infrastructure. A major advancement for a sustainable and innovative future.

Source: Grupoacs, published under the title "ACS is joined by Global Infrastructure Partners to launch a ..." - 14 November 2025

ACS Accelerates Its Global Data Center Expansion

ACS solidifies its global leadership in data centers with over 9 GW installed and an ambitious partnership with GIP to reach 3 GW by 2030. The group's strategy accelerates growth in AI, semiconductors, and sustainable infrastructure, while enhancing shareholder returns with dividends of nearly €3.5 per share and a 102% increase in stock price. An innovative vision for the digital future.

Source: Grupoacs, published under the title "ACS accelerates global growth through its Data Center and Di..." - 14 November 2025

ACS Group: Net Profit Rises 11.6% to €655 Million in 2025

ACS Group is in full acceleration: Record sales of €36.75 billion (+23.7%), EBITDA up 32% to €2.22 billion, and a backlog of €89.27 billion (+8.9%). Strategic investments of €1.25 billion boost data centers and sustainable infrastructure, with attributable net profit of €655 million (+8.3%). A year of robust and diversified growth!

Source: Grupoacs, published under the title "ACS Group achieves a net profit of €655 million in the third..." - 14 November 2025

Innovative Partnership: Warringah and KADYN for a Sustainable Sydney

"Innovative partnership between Warringah Freeway Upgrade and KADYN: Supporting at-risk youth through sustainable jobs and green infrastructure projects, such as drainage and landscaping. For over a decade, this collaboration has fostered an inclusive and sustainable construction industry, integrating plant technologies for a positive impact on the community and the environment."

Source: Cimic, published under the title "Partnering for purpose: Warringah Freeway Team and KADYN" - 14 November 2025

Sanofi's Teizeild: A Breakthrough Against Type 1 Diabetes

Sanofi's Teizeild: A Major Advancement in Delaying Type 1 Diabetes in Europe The CHMP recommends approval of this innovative treatment, based on the TN-10 study, which shows a median delay of two years to stage 3 for stage 2 patients, both adults and children aged 8 and older. If approved, Teizeild would become the first disease-modifying therapy for T1D in the EU, offering concrete hope for early and less invasive management. Sanofi reaffirms its commitment to transforming the care of autoimmune diabetes. This step forward could revolutionize therapeutic options by targeting autoimmunity from its onset. Approvals are already in place in several countries, marking a new era in endocrinology.

Source: Sanofi, published under the title "Press Release: Sanofi’s Teizeild recommended for EU approval..." - 13 November 2025

Mechanization & Robotics

AGCO Wins Seven AE50 2026 Awards for Agricultural Innovation

AGCO, a global leader in the design and manufacturing of agricultural machinery, has been honored with seven AE50 2026 awards by ASABE. These accolades highlight innovative products such as high-performance tractors and automation systems, reinforcing AGCO's position as a provider of tailored solutions for farmers. The awarded innovations aim to optimize efficiency and comfort in agricultural operations while addressing contemporary challenges in agriculture.

Source: Agco, published under the title "AGCO Brands Win Seven 2026 AE50 Awards" - 13 November 2025

Losinger Marazzi: An Innovative Eco-Project for Zug by 2030

Losinger Marazzi is reinventing Zug's infrastructure with a CHF 242 million project for modern facilities dedicated to public transport (ZVB), emergency services (RDZ), and cantonal administration. Spanning 26,000 m² and meeting the Minergie-P-ECO standard, this transformation will provide an efficient and sustainable work environment, supporting the growth of the thriving canton. Construction will begin in 2026 for completion in 2030.

Source: Bouygues Construction, published under the title "Un nouveau contrat pour Losinger Marazzi, filiale suisse de ..." - 13 November 2025

T3 2025: Merck Boosts Organic Growth Across All Sectors

Merck reports a solid organic growth of 5.2% for its net sales, reaching €5.3 billion, with a pre-EBITDA increase of 8.8% to €1.7 billion. Remarkable performances in process solutions, rare diseases, and semiconductors bolster this momentum, despite currency headwinds. The company reaffirms its ambitious guidance for 2025.

Source: Merck, published under the title "Q3 2025: Merck Shows Solid Organic Growth Across All Sectors" - 13 November 2025

Abertis Extends Its Concession in Brazil Until 2047

Arteris extends its concession of the BR-101/RJ Norte until 2047: a €500 million investment to modernize 322 km of highways, enhance mobility and safety for 9.4 million residents, and strengthen Abertis's strategic position as a leader in infrastructure in Brazil, with exemplary management of over 3,000 km of roads. This operation illustrates the group's commitment to sustainable growth and financial optimization in a key market.

Source: Grupoacs, published under the title "Abertis extends its concession in Rio de Janeiro until 2047" - 12 November 2025

Ryan Field: Topping Out Celebration for the Innovative Stadium!

The final steel beam was placed at Ryan Field: a major milestone for this $850 million private project in Evanston, marking the completion of the structure and a commitment to sustainability. With inspiring speeches from local leaders and the Ryan family, this stadium aims for LEED Gold certification, combining technical innovation, community green spaces, and an intimate design for the future of college sports. A collective celebration of progress and environmental responsibility.

Source: Hochtief, published under the title "Northwestern and Turner-Walsh Joint Venture Celebrate Toppin..." - 12 November 2025

Novartis: GanLum Overcomes Malaria Resistance in Phase III Trials

New breakthrough against malaria: Novartis' GanLum excels in Phase III trials with a 97.4% cure rate, surpassing standard treatment and targeting resistant parasites. Developed with MMV, this innovative treatment could block transmission and represents the first major innovation in 25 years, strengthening the fight in Africa. Novartis aims for rapid approval for global distribution.

Source: Novartis, published under the title "Novartis Phase III trial for next-generation malaria treatme..." - 12 November 2025

Bayer Confirms Its 2025 Goals and Advances in Agritech

Bayer is in full acceleration: Group sales reach €9.66 billion (+0.9% adjusted), EBITDA before special items rises by 20.8% to €1.51 billion, and Crop Science experiences strong growth driven by agricultural innovations. Despite legal challenges, the 2025 outlook is confirmed, showcasing marked resilience in agritech. The Pharma and Consumer Health divisions remain on track.

Source: Bayer, published under the title "Bayer confirms 2025 Group outlook, progresses on strategic p..." - 11 November 2025

Bayer Triumphs in Agritech: Q3 2025 Results Unveiled!

Discover Bayer's agritech innovations for 2025: Confirmation of the group's outlook, third-quarter revenue figures, and exclusive access to photos and recordings. Stay informed about advancements in plant technologies and sustainable seeds. Sign up for our newsletter to not miss any strategic updates!

Source: Bayer, published under the title "Bayer AG Third Quarter 2025 Results and Media Update" - 11 November 2025

North East Link: Platinum in Innovative Sustainability

Victoria's North East Link project achieves Platinum IS Design v2.1 certification, a groundbreaking feat in sustainable infrastructure. With a 95% reduction in carbon emissions and a 'World First' innovation in indigenous co-design, this national benchmark demonstrates that large-scale projects can be both eco-friendly and cutting-edge, inspiring the industry towards a greener future. Delivered by the Spark consortium, it combines performance with environmental protection for communities.

Source: Cimic, published under the title "Setting the standard in sustainability and innovation" - 11 November 2025

Rockefeller Group Completes Its Iconic Tower in Atlanta

Rockefeller Group finalizes the 60-story tower at 1072 West Peachtree, Atlanta: an innovative LEED Silver project combining premium office spaces, luxury residences with an acre of resort-style indoor and outdoor amenities – including an athletic club, a Pilates studio, and a pickleball court – plus 6,300 square feet of retail on the ground floor. Set to open in 2026, this urban giant redefines mixed-use living in the heart of Midtown.

Source: Hochtief, published under the title "Rockefeller Group Celebrates Topping Out at 1072 West Peacht..." - 11 November 2025